Assessment of Atherosclerotic Plaques in the Rabbit Abdominal Aorta with Interleukin-8 Monoclonal Antibody-Targeted Ultrasound Microbubbles

Yongping Lu,Jia Wei,Qinghua Shao,Yueyue Tang,Yanling Huang,Huali Zhang,Wei Yang,Zhi Jing
DOI: https://doi.org/10.1007/s11033-012-2382-5
IF: 2.7422
2013-01-01
Molecular Biology Reports
Abstract:In this study, we aimed to prepare a neovascularization-relevant inflammatory cytokine-targeted ultrasound contrast agent and apply it in the ultrasound imaging of atherosclerotic plaque. An interleukin-8 (IL-8) monoclonal antibody was conjugated to SonoVue microbubbles using the N-succinimidyl-3-(2-pyridyldithio)propionate cross-linking method. Then, a prepared IL-8-targeted contrast agent was used for contrast-enhanced ultrasound (CEU) to detect rabbit abdominal aorta atherosclerotic plaque and to investigate the imaging characteristics of atherosclerotic plaque with the contrast agent. We found that an IL-8 monoclonal antibody can be successfully coupled to SonoVue microbubbles with stable biological characteristics. CEU with this IL-8-targeted contrast agent can increase the atherosclerotic plaque detection sensitivity, with stronger echo, so that three more plaques were detected compared with using non-targeted SonoVue microbubbles. Thus, an inflammatory cytokine-targeting ultrasound contrast agent carrying IL-8 monoclonal antibody can provide unique advantages for researching the characteristics of atherosclerotic plaque.
What problem does this paper attempt to address?